What is PotBotics?
PotBotics operates as a sophisticated data aggregation and technology enterprise, specifically engineered for the medical cannabis industry. The company leverages a proprietary artificial intelligence platform designed to correlate HIPAA-compliant medical data, enabling clinicians and patients to personalize treatment protocols with unprecedented precision. Beyond its software capabilities, the firm is expanding its hardware footprint with the introduction of RYAH, the world's first dose-measuring vaporizer. This device serves as a critical touchpoint for gathering real-time consumption metrics, which, when combined with the company's extensive intellectual property portfolio, provides a comprehensive view of the cannabis lifecycle from cultivation to patient administration.
How much funding has PotBotics raised?
PotBotics has raised a total of $2.4M across 1 funding round:
Debt
$2.4M
Debt (2014): $2.4M, investors not publicly disclosed
Key Investors in PotBotics
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for PotBotics?
With this major strategic investment, PotBotics is positioned to accelerate the commercial rollout of the RYAH ecosystem. The firm's roadmap focuses on deepening its analytical capabilities to provide actionable business intelligence and clinical insights that could redefine standard practices in cannabinoid therapy. As the company moves into this next phase of growth, the integration of hardware-derived data into its existing AI framework will likely serve as a primary driver for long-term value creation and industry leadership in the medical cannabis technology space.
See full PotBotics company page
